Neuroendocrine differentiation predicts the therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancerNanwei Xu, Hao Zeng|Journal of Cancer Research and Clinical Oncology|2023Cited by 6